BIOTRICITY INC. (BTCY)
Q3-CY2026Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014
Balance Sheet Date2026-Mar-312025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312020-Jun-302019-Jun-302018-Jun-302017-Jun-302016-Mar-312015-Aug-312015-May-31
Fiscal PeriodQ4-FY2026Q3-FY2026Q2-FY2026Q1-FY2026Q4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q4-FY2020Q4-FY2019Q4-FY2018Q4-FY2017Q3-FY2016Q4-FY2015Q3-FY2015
Operating Cash Flow(20,905$)(740,291$)415,630$(373,389$)(400,785$)(88,093$)(397,059$)(1,494,240$)(1,165,792$)(1,832,118$)(2,393,110$)(1,328,375$)(1,209,549$)(1,284,885$)(1,086,461$)(578,567$)(551,511$)(827$)(586,133$)(3,604$)(1,478$)
Investing Cash Flow0$0$0$
Purchases of Property and Equipment
Financing Cash Flow(91,546$)721,325$(507,748$)435,705$165,020$424,960$471,099$868,180$1,788,504$1,329,145$1,573,987$1,329,802$550,835$1,926,780$1,486,102$673,205$225,724$5,237$235,379$3,604$1,478$
End Cash Position149,789$256,357$308,460$391,292$365,145$509,601$173,270$100,731$786,060$85,094$570,460$2,201,562$3,324,190$470,174$64,875$949,848$4,353,762$42,732$63,647$83,254$202,653$843,643$2,482,262$607,149$1,192,832$424,868$20,659$23,783$33,898$53,643$36,238$135,295$448,599$0$0$
Exchange Rate Effect5,883$(33,137$)9,286$(36,169$)245,156$(535$)(1,501$)(59,269$)78,254$(16,054$)(65,851$)(17,324$)17,724$
Dividends Paid6,000$6,000$6,116$5,852$
Unlevered Free Cash Flow(20,905$)(740,291$)415,630$(373,389$)(400,785$)(88,093$)(397,059$)(1,494,240$)(1,165,792$)(1,832,118$)(2,393,110$)(1,328,375$)(1,209,549$)(1,284,885$)(1,086,461$)(578,567$)(551,511$)(827$)(586,133$)(3,604$)(1,478$)